Stem Cell Hair Restoration: What the Evidence Shows

Table of contents

• What stem cell hair restoration actually is
• Does stem cell hair restoration work? The trials
• Three claims that do not match their source
• Conditioned medium and exosomes: cell-free products
• What a "stem cell hair transplant" means
• What the FDA has and has not approved
• Stem cell hair treatment cost
• Side effects and risks
• Where it is unlikely to help
• What has stronger evidence
• Questions to ask before paying
• Frequently Asked Questions

What stem cell hair restoration actually is

Stem cell hair restoration is an umbrella term for at least five products, and only some of them contain live stem cells. The table sorts them by what goes into the scalp.

What is sold	What goes into the scalp	Live cells?	Where it comes from
Fat-derived cell injection (SVF, ADRCs)	Cells concentrated from your own liposuctioned fat, often mixed with fat graft	Yes, a mixed population	Your abdomen or hip
Scalp-tissue suspension ("micrografts")	Tissue from a scalp punch biopsy, mechanically broken up and injected	Yes, a small fraction are stem cells	Your own scalp
Cultured follicle cells	Cells grown in a lab from your own follicles	Yes	Your own scalp
Conditioned medium, cell extracts, exosomes	Proteins, growth factors or vesicles that cells released in culture	No	Usually donor cells, processed by a manufacturer
PRP sold as "regenerative" or "stem cell"	Concentrated platelets from your blood	No	Your blood

The last row matters more than it looks. The American Hair Loss Association warned in 2025 that "many providers are rebranding platelet-rich plasma (PRP) ... as 'stem cell' therapy" and that PRP "does not contain stem cells" (AHLA advisory, April 2025). The same advisory says some umbilical or amniotic "stem cell" injections contain "no live stem cells at all". PRP has its own, modest evidence base, set out in hair transplant vs PRP.

Does stem cell hair restoration work? The trials

Placebo-controlled studies of live-cell injections for stem cell hair restoration are small, and they disagree. The table shows three from three different research groups, with design and funding, because those details explain the headline numbers.

Study	What was injected	People who got cells	Control	Result	Who ran or funded it
Gentile et al, Stem Cell Investig 2017	Scalp-tissue suspension, 2 sessions 60 days apart	11 patients aged 38 to 61, Norwood 3 to 5	Saline in a different scalp region of the same patient	+29% density in treated area vs under 1% in saline area, 23 weeks after last session	University group; no conflicts declared
Kuka et al, Aesthet Surg J 2020	Fat graft enriched with fat-derived cells, two doses	38 (16 + 22)	Fat alone (24), saline (9), randomised	No statistically significant difference between any groups in terminal hair count or width at 24 weeks; in a Norwood 3 subgroup analysis, the low dose differed from saline (P = 0.03)	Funded by Kerastem, the device maker, which "participated in the design ... analysis ... and writing"
Tsuboi et al, J Am Acad Dermatol 2020	Cultured dermal sheath cup cells, three doses, one injection	65 (50 men, 15 women)	Placebo in a fourth scalp region, randomised, double-blind	Only the lowest dose was reported as significantly better than placebo, at 6 and 9 months; authors note the effect "was temporary until 9 months"	Two authors from Shiseido's regenerative medicine unit, which developed the cells

Add up the third column and you get 114 people who received live cells across these three trials. For comparison, finasteride's registration trials put 945 men on the drug in their first year alone, according to the FDA label.

The Italian group behind the first study has since reported bigger effects with the same half-head approach. In 27 patients given scalp micrografts, density in the treated area rose by 23.3 hairs per cm² after 58 weeks while the saline side fell by 0.7, and six patients needed retreatment after 26 months (Gentile et al, Biomed Res Int 2020). A second study from the group, with 35 patients enrolled, reported a 33% density gain over baseline 23 weeks after the last of three sessions (Gentile, Int J Mol Sci 2019). Both come from one group and compare two halves of the same scalp, and the trials in the table from other groups did not find gains of that size.

Uncontrolled studies report gains too, such as a rise from about 131 to 152 hairs per cm² six months after one fat-derived cell injection in 30 people (El-Khalawany et al, Arch Dermatol Res 2023). Without a control group, that cannot be separated from seasonal shedding or the effect of needling itself.

The most recent systematic review, covering 20 studies and 724 patients across five regenerative approaches, called the results encouraging but flagged "heterogeneity in study protocols and limited long-term data" and asked for larger randomised trials (Behrangi et al, Stem Cell Res Ther 2026).

Three claims that do not match their source

Three claims that circulate on stem cell hair restoration clinic pages and health sites do not hold up against their source.

"29% more hair density in under two months." The 29% comes from the 11-patient Italian study, and it was measured 23 weeks after the last of two sessions, not within two months. The comparison area was a different part of the same scalp (frontal treated, parietal given saline, for example), regions were not reported as randomised, and different scalp regions do not thin at the same rate. Each suspension contained about 3,700 cells, of which roughly 5% carried a dermal papilla stem-cell marker and 2.6% a bulge stem-cell marker (Gentile et al 2017). That works out to a few hundred marked cells per suspension.

"A South Korean stem cell transplant study showed a 28% increase in hair density." That trial did not transplant or inject any cells. Participants rubbed a topical extract made from donor fat-derived stem cells onto their scalp twice a day for 16 weeks. Hair count rose 28.1% against 7.1% on the vehicle, in a randomised trial of 38 people of whom 34 completed it (Tak et al, Stem Cells Transl Med 2020). The extract was manufactured and supplied by a company that is also listed as the affiliation of one of the four authors, although the authors declared no conflicts of interest. It is a reasonable small trial of a cell-free product, but it says nothing about injecting cells.

"Slit grafts and micrografts are FDA-approved hair transplant procedures." The FDA approves drugs and biologics and clears devices. It does not approve surgical techniques, so no transplant method is "FDA-approved". The distinction matters here because the FDA has explicitly said cell and exosome products are within its jurisdiction, as the regulation section below explains.

Conditioned medium and exosomes: cell-free products

Cell-free products have more trials than live-cell injections, and the pooled effect is modest. Conditioned medium is the fluid that stem cells have grown in, and it carries the proteins and growth factors they secrete. A 2024 meta-analysis pooled eight trials with 221 patients and found a mean difference in hair density of 14.93 (95% CI 10.20 to 19.67). When it was restricted to the three randomised trials, the difference fell to 9.23 (95% CI 1.79 to 16.68), a wide range built on few patients (Chien et al, J Plast Reconstr Aesthet Surg 2024).

Exosomes are tiny vesicles released by cells, and they are now the most heavily marketed version. A 2026 systematic review of 39 preclinical and clinical studies reported density gains of 8 to 20% in early clinical studies. It also said the evidence "remains limited by small sample sizes, retrospective designs, lack of control groups, and inconsistent outcome measures" and that manufacturing is not standardised (Malih et al, Mol Biol Rep 2026).

Two vials both labelled "exosomes" can come from different cell types and manufacturers, so a trial of one product says little about another. The AHLA says many topical exosome products sold online have "no verified origin, no quality assurance".

What a "stem cell hair transplant" means

A stem cell hair transplant usually means one of three different things, and none of them grows new follicles from cells.

1. An injection described as a transplant. A small punch of scalp is broken up and the suspension is injected into thinning areas, as in the Italian study above. Nothing is transplanted in the surgical sense, and the follicles that already exist are the only ones that can respond.
2. A partial-follicle FUE. Only part of each follicle is removed, on the theory that the stem cells left behind regrow a hair in the donor area. That theory comes mainly from papers by the technique's developer (Gho and Neumann, Curr Probl Dermatol 2015), and we found no independent controlled data on donor regrowth.
3. An ordinary FUE with a "stem cell" add-on, often fat-derived cells, an exosome vial or PRP applied to the grafts. The surgery is standard; only the add-on has a new name.

True "hair cloning" (multiplying your follicles in a lab and implanting the result) is not an approved or established treatment. A 2014 review column on the ISHRS site noted that several groups that had tried implanting cultured cells to create new follicles over the previous ten years had been unsuccessful (ISHRS Forum review). Of the human studies since, the best-controlled is the Japanese trial in the table, and it produced a temporary increase in density rather than new follicles.

The same renaming happened with DHI, where a placement tool is sold as a separate procedure. How a hair transplant works explains what the standard operation does.

What the FDA has and has not approved

The FDA has approved no stem cell, cell-derived or exosome product for hair loss. The stem cell products it has approved treat blood and immune conditions: blood-forming cells from umbilical cord blood and, since December 2024, a bone-marrow-derived mesenchymal stromal cell product for steroid-refractory graft-versus-host disease in children (FDA, December 2024). The FDA's patient and consumer page on regenerative medicine therapies lists stromal vascular fraction, cord blood, amniotic fluid, Wharton's jelly and exosomes among unapproved products, and says the agency has received reports of blindness, tumour formation and infections linked to them.

On exosomes specifically, the FDA issued a public safety notification in December 2019 after serious adverse events in Nebraska patients. It stated there are "currently no FDA-approved exosome products" and that exosomes used to treat disease are regulated as drugs and biological products.

Fat-derived cells have been tested in court. In June 2021 the US Court of Appeals for the Eleventh Circuit upheld the FDA's position that a Florida clinic's stromal vascular fraction product was subject to FDA regulation as a drug, and rejected the argument that reinjecting a patient's own processed cells fell under the same-surgical-procedure exemption (United States v. US Stem Cell Clinic, 998 F.3d 1302). The clinic marketed the product for other conditions, but it was made the way fat-derived hair injections are made: fat processed into stromal vascular fraction and reinjected.

In practice, a legitimate live-cell hair treatment in the US is one given inside a registered clinical trial. The AHLA says these therapies "must be part of a regulated clinical trial or IRB-approved study to be ethically and legally administered".

Stem cell hair treatment cost

Stem cell hair treatment is commonly priced in the thousands of dollars per session, and the trials suggest any benefit may need repeating. Healthline reports investigational clinic prices of $3,000 to $10,000, reaching $25,000 depending on the area treated. We found no independent price survey for hair specifically. The nearest comparison is a mystery-shopper study of US clinics selling stem cell knee injections, which found a mean of $5,156 per injection among the 65 clinics that quoted a price (Piuzzi et al, J Knee Surg 2018).

The trials themselves suggest repeat sessions. The gain in the Japanese trial lasted about nine months. The Kerastem investigators wrote that "frequent interventions are necessary to counter the constant forces of follicular miniaturization" (Kuka et al 2020). Neither study measured a repeat schedule, so the table below shows illustrative totals, not a predicted bill.

Price per session	One session a year, 5 years	Two sessions a year, 5 years
$3,000	$15,000	$30,000
$5,000	$25,000	$50,000
$10,000	$50,000	$100,000

As a surgical add-on, it is priced very differently. The cost calculator lists stem cell treatments with PRP and sapphire blades among extras sold on top of the base price. The Turkey cost page shows which add-ons appear in package quotes there. If a clinic quotes either form, it is worth pricing the transplant on its own first, so you can see what the add-on costs.

Side effects and risks

The trials reported few serious side effects, but they were small and brief. In the Kerastem trial the procedure began with liposuction under local anaesthetic, with or without sedation, and the investigators reported "no unanticipated associated adverse events" (Kuka et al 2020). The Japanese trial reported no serious adverse events. In the topical extract trial, seven mild events occurred in five participants, with no difference between groups (Tak et al 2020).

A clean record in a few hundred trial participants, followed for a year or less, does not cover the risks that matter most outside a trial:

• The harvest. Fat-derived treatments need liposuction, which brings bruising, swelling, numbness and a small risk of infection at the donor site. Scalp-tissue methods need a punch biopsy, which leaves a small scar.
• Contamination and product identity. The FDA's alerts concern exactly this: unapproved products that may be contaminated, mislabelled or contain nothing active.
• Shedding at the injection site. The Kerastem trial tracked injection-site telogen effluvium (temporary shedding) as a related adverse event, a reminder that needling the scalp can cause shedding by itself.

Where it is unlikely to help

Stem cell hair restoration is unlikely to help on a scalp that is already bare, because every version works by acting on follicles that are still there. A summary on the ISHRS site of an interview with Imperial College hair researcher Claire Higgins puts it plainly: stem cells "do not directly enlarge hair follicles", they act through signals that may prolong the growth phase, and "stem cell therapy does not reverse miniaturization but rather delays it" (ISHRS).

Stage matters. In the Kerastem trial, the only signal came from a Norwood 3 subgroup. At Norwood 6, where the top of the head has few follicles left, neither the mechanism nor any trial suggests a meaningful result. The Norwood stage finder shows where you sit in about a minute.

What has stronger evidence

Finasteride and minoxidil are the treatments for pattern hair loss with large trials behind them, and a transplant is the only option that adds follicles to bare areas. Finasteride is the usual first-line option for men: the finasteride results page sets out what the five-year data showed. Its trade-off is sexual side effects: in the registration trials, 3.8% of men on finasteride reported a sexual adverse experience in the first year against 2.1% on placebo (FDA label). The full picture is in finasteride side effects.

Topical minoxidil is available without a prescription and is used by men and women; minoxidil results covers the timeline. Its common side effects are scalp itching and irritation and a temporary shed in the first months. Unwanted facial or body hair was spontaneously reported by 50 of 1,333 women (4%) in placebo-controlled trials, a total that includes the placebo groups, with reports more frequent at 5% than at 2% strength (Dawber and Rundegren, J Eur Acad Dermatol Venereol 2003).

The newer science is in drug trials. PP405, a topical gel designed to act on hair follicle stem cells, is a drug rather than a cell product. In a 78-person phase 2a trial, 31% of men with more advanced loss had a greater than 20% density increase at week 8 against 0% on placebo. That was an exploratory result, as the primary endpoint was safety, and in June 2025 the company said it planned phase 3 trials in 2026 (Dermatology Times, June 2025). It is not approved, and its side-effect profile in large, longer trials is not yet known.

Questions to ask before paying

A clinic offering stem cell hair restoration should be able to answer these in writing.

• What exactly will be injected or applied? Live cells, a cell-free extract, exosomes or PRP? From your tissue or a donor?
• Who makes it, and is there a certificate of analysis showing what each batch contains and that it was tested for sterility?
• Is this part of a registered clinical trial? In the US, ask for the ClinicalTrials.gov number and the IRB approval. Outside a trial, ask what the regulatory basis is for offering it.
• What published, controlled study used this exact product and protocol, and what was the result at 12 months?
• How many sessions, how often, and what happens if you stop?
• Who performs the harvest and the injection, and what are their qualifications?

Frequently Asked Questions

Is stem cell hair restoration FDA approved?

No. The FDA has approved no stem cell, cell-derived or exosome product for hair loss. Its approved stem cell products treat blood and immune conditions. A federal appeals court has upheld FDA regulation of a clinic's fat-derived cell product as a drug.

How long do stem cell hair results last?

The evidence suggests not long without repeats. In the best-controlled trial, the benefit at the effective dose was significant at 6 and 9 months and the authors describe it as temporary. Researchers involved in the fat-derived cell trial wrote that frequent treatments would be needed to counter ongoing miniaturisation.

Is a stem cell hair transplant better than FUE?

They do different jobs. FUE moves existing follicles into bare areas and the grafted hair is resistant to pattern loss. Stem cell treatments act on thinning follicles that are still present, and the controlled evidence shows small, temporary effects at best. A "stem cell hair transplant" sold at a clinic is usually an FUE with an add-on, so it is worth separating the two prices.

Can stem cells regrow hair on a completely bald scalp?

There is no evidence that they can. Every trial covered here enrolled people with thinning hair, and the proposed mechanism works by prolonging the growth phase of existing follicles.

Stem cell hair restoration is still a research field. If you are weighing it against established options, a board-certified dermatologist or a hair restoration surgeon can examine your scalp, confirm the type of hair loss and explain which treatments fit your stage.